Matthew Pratt Whalen

Insider Reports History

Entity
Individual
Location
855 N Wolfe Street,, Suite 601, Baltimore, MD
Signature
/s/ Matthew Pratt Whalen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Pratt Whalen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Telomir Pharmaceuticals, Inc. Director Incentive Stock Options (right to buy) 25K Aug 27, 2024 Direct

Insider Reports Filed by Matthew Pratt Whalen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TELO Telomir Pharmaceuticals, Inc. Aug 27, 2024 1 $0 4 Aug 29, 2024 Director
TELO Telomir Pharmaceuticals, Inc. Aug 8, 2024 0 $0 3 Aug 15, 2024 Director